Bioprospecting of Selected Species of Polypore Fungi from the Western Balkans
- PMID: 38257227
- PMCID: PMC10819588
- DOI: 10.3390/molecules29020314
Bioprospecting of Selected Species of Polypore Fungi from the Western Balkans
Abstract
Growing mushrooms means meeting challenges while aiming for sustainability and circularity. Wherever the producer is located, commercial strains are the same originating from several producers. Customized strains adapted to local conditions are urgently needed. Before introducing new species to the strain development pipeline, the chemical characterization and biological activity of wild ones need to be assessed. Accordingly, the mycoceutical potential of five polypore mushroom species from Serbia was evaluated including: secondary metabolite composition, oxidative damage prevention, anti-tyrosinase, and anti-angiotensin converting enzyme (ACE). The phenolic pattern was comparable in all samples, but the amounts of specific chemicals varied. Hydroxybenzoic acids were the primary components. All samples had varying quantities of ascorbic acid, carotene, and lycopene, and showed a pronounced inhibition of lipid peroxidation (LPx) and ability to scavenge HO•. Extracts were more potent tyrosinase inhibitors but unsuccessful when faced with ACE. Fomitopsis pinicola had the strongest anti-tumor efficacy while Ganoderma lucidum demonstrated strong selectivity in anti-tumor effect in comparison to normal cells. The evaluated species provided a solid foundation for commercial development while keeping local ecology in mind.
Keywords: Coriolus; Fomitopsis; Ganoderma; biological activity; bioprospecting; mushroom cultivation; oxidative damage prevention; polypore.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Effects on tyrosinase activity by the extracts of Ganoderma lucidum and related mushrooms.Mycopathologia. 2008 Aug;166(2):117-20. doi: 10.1007/s11046-008-9128-x. Epub 2008 May 6. Mycopathologia. 2008. PMID: 18459064
-
Antioxidant and anticholinesterase activities of five wild mushroom species with total bioactive contents.Pharm Biol. 2015 Jun;53(6):824-30. doi: 10.3109/13880209.2014.943245. Epub 2015 Feb 27. Pharm Biol. 2015. PMID: 25720975
-
In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2.J Biomol Struct Dyn. 2023 Mar;41(5):1574-1585. doi: 10.1080/07391102.2021.2023048. Epub 2021 Dec 31. J Biomol Struct Dyn. 2023. PMID: 34971338
-
Selenium in edible mushrooms.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Jul-Sep;26(3):256-99. doi: 10.1080/10590500802350086. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008. PMID: 18781538 Review.
-
Structure and inhibition mechanism of some synthetic compounds and phenolic derivatives as tyrosinase inhibitors: review and new insight.J Biomol Struct Dyn. 2023 Jul;41(10):4798-4810. doi: 10.1080/07391102.2022.2069157. Epub 2022 May 5. J Biomol Struct Dyn. 2023. PMID: 35510568 Review.
Cited by
-
Enhancement of antioxidant activity and total phenolic content of Fomitopsis pinicola mycelium extract.Fungal Biol Biotechnol. 2024 Nov 7;11(1):18. doi: 10.1186/s40694-024-00187-0. Fungal Biol Biotechnol. 2024. PMID: 39511671 Free PMC article.
-
Comparative evaluation of free radical scavenging activity and total metabolite profiles among 30 macrofungi species.Bioresour Bioprocess. 2025 Feb 21;12(1):13. doi: 10.1186/s40643-025-00841-4. Bioresour Bioprocess. 2025. PMID: 39982581 Free PMC article.
-
Cytotoxic activity of Fomitopsis betulina against normal and cancer cells - a comprehensive literature review.Contemp Oncol (Pozn). 2024;28(3):191-200. doi: 10.5114/wo.2024.144223. Epub 2024 Oct 15. Contemp Oncol (Pozn). 2024. PMID: 39512529 Free PMC article. Review.
References
-
- European Parliament Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on Novel Foods, Amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and Repealing Regulation (EC) No 258/97 of the European Parliam. Off. J. Eur. Union. 2015;L327:1–22.
-
- Vunduk J., Tura D., Biketova A.Y. Medicinal Mushroom Nutraceutical Commercialization: Two Sides of a Coin. In: Dhull S.B., Bains A., Chawla P., Sadh P.K., editors. Wild Mushrooms Characteristics, Nutrition, and Processing. CRC Press; Boca Raton, FL, USA: 2022. p. 43.
-
- Almádi B. The Producer and Consumer Aspects of the Mushroom Sector in Hungary. Szent István University; Gödöllő, Hungary: 2021.
-
- Bringye B., Fekete-Farkas M., Vinogradov S. An Analysis of Mushroom Consumption in Hungary in the International Context. Agriculture. 2021;11:677. doi: 10.3390/agriculture11070677. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous